Skip to main content

Table 2 All PIVC characteristics during insertion

From: Occurrence and incidence rate of peripheral intravascular catheter-related phlebitis and complications in critically ill patients: a prospective cohort study (AMOR-VENUS study)

Variables Total
n = 7118
Location of insertion
 ICU 3429/7115 (48.2%)
 ER 1310/7115 (18.4%)
 Others (ward, OR, outpatients) 2376/7115 (33.4%)
Inserted site (n,%)
 Upper arm 473/7097 (6.7%)
 Forearm 3986/7097 (56.2%)
 Elbow 355/7097 (5.0%)
 Wrist 286/7097 (4.0%)
 Hand 1514/7097 (21.3%)
 Lower leg 283/7097 (4.0%)
 Dorsal foot 169/7097 (2.4%)
 Others 31/7097 (0.4%)
Catheter material (n,%)
 PEU-Vialona 2120/7118 (29.8%)
 Polyurethane 1968/7118 (27.7%)
 Polyethylene 0/7118 (0%)
 Tetrafluoroethylene 2695/7118 (37.9%)
 Others 335/7118 (4.8%)
Catheter gauge (n,%)
 14G 10/7009 (0.1%)
 16G 386/7009 (5.5%)
 18G 595/7009 (8.5%)
 20G 2464/7009 (35.2%)
 22G 3432/7009 (49.0%)
 23G 1/7009 (0.01%)
 24G 121/7009 (1.7%)
Dressing (n,%)
 Chlorhexidine-impregnated dressing 1/7043 (0.01%)
 Sterile polyurethane dressing 6844/7043 (97.2%)
 Non-sterile polyurethane dressing 85/7043 (1.2%)
 Gauze dressing 2/7043 (0.03%)
 Tape dressing 111/7043 (1.6%)
Any infection during catheterization (n,%) 1267 (17.8%)
Duration of catheterization, median (IQR), hours 36.0 (19.0-71.0)
Removal in ICU (n, %) 3705/7103 (52.2%)
  1. ICU intensive care unit, IQR interquartile range, PIVC peripheral intravenous catheter, ER emergency room, OR operation room, aPEU-Vialon polyetherurethane without leachable additives